ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2644

The Relationship Between Disease Activity and Cognitive Impairment in Patients with Rheumatoid Arthritis

Sang-Il Lee1, Young Sun Suh1, Yun-Hong Cheon1, Hyun-Ok Kim1, Hyun-Su Yang2, Ki-Soo Park2, Eun-Kyoung Park3, Seung-Geun Lee4, Chang-Nam Son5, Ji-Min Kim5 and Sang-Hyon Kim6, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 2Department of Preventive Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Busan National University School of Medicine, Busan, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea, 6Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cognitive dysfunction and rheumatoid arthritis (RA), Disease Activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Only few studies investigated the prevalence and risk factors of cognitive impairment in patients with rheumatoid arthritis (RA), however, results are controversial. Therefore we performed this study to determine the prevalence and risk factors of cognitive impairment and their association with RA disease activity.

Methods: Patients with RA and osteoarthritis (OA) were recruited from 3 university hospitals and physical, psychosocial, laboratorial, and medication statuses were assessed. Patients under 45 years old or with illiteracy were excluded. The activity and functional status of RA were assessed by Disease activity score (DAS)-ESR and Routine Assessment of Patient Index Data 3 (RAPID 3) score. Cognitive function was evaluated by Korean version of Mini-Mental State Examination (MMSE-K). Cognitive impairment was defined as MMSE-K scores ≤ 23.

Results:  A total of 506 RA and 202 OA patients were recruited. Cognitive impairment was observed in 10.5%in RA and 13.4% in OA (P=0.272). In subgroup analysis between RA patients with cognitive impairment (n=53) or not (n=453), education level (OR 0.72, 95% CI 0.64-0.80), marriage status (OR 2.12, 95% CI 1.02-4.41), and high disease activity (OR 2.84, 95% CI 1.08-7.48) were independently predicted cognitive impairment after multivariate analysis controlling for age, hypertension, exercise, RAPID 3 score, fatigue, depression, and medication use. In subgroup analysis between RA patients with high disease activity (DAS28-ESR>5.1, n=55) or without (n=448), high disease activity was strongly associated with cognitive impairment (25.5% vs 8.5%, P=0.001). The education level was 63.8±9.96 and 62.1±8.51 (P=0.250) and age was 7.9±4.42 and 8.8±3.82 (P=0.111). In addition, DAS28-ESR score showed negative correlation with MMSE-K score (ρ=-0.110, P<0.05).

Conclusion: High disease activity is strongly associated with cognitive impairment in patients with RA. Thus, controlling disease activity may help preserving cognitive function in RA.


Disclosure: S. I. Lee, None; Y. S. Suh, None; Y. H. Cheon, None; H. O. Kim, None; H. S. Yang, None; K. S. Park, None; E. K. Park, None; S. G. Lee, None; C. N. Son, None; J. M. Kim, None; S. H. Kim, None.

To cite this abstract in AMA style:

Lee SI, Suh YS, Cheon YH, Kim HO, Yang HS, Park KS, Park EK, Lee SG, Son CN, Kim JM, Kim SH. The Relationship Between Disease Activity and Cognitive Impairment in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-relationship-between-disease-activity-and-cognitive-impairment-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-relationship-between-disease-activity-and-cognitive-impairment-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology